ASX:LSH

Lifespot Health Competitors

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume120,633 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Lifespot Health (ASX:LSH) Vs. BUX, IME, BD1, CRL, CTE, and DVL

Should you be buying LSH stock or one of its competitors? Companies in the industry of "diagnostics & research" are considered alternatives and competitors to Lifespot Health, including (BUX) (BUX), 12144 (IME), BARD1 Life Sciences (BD1), Charles River Laboratories International (CRL), Cryosite (CTE), and dorsaVi (DVL).

Lifespot Health vs. (BUX) Stock

Lifespot Health (ASX:LSH) and (BUX) (CNSX:BUX) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, analyst recommendations, dividends and profitability.

Earnings and Valuation

This table compares Lifespot Health and (BUX)'s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifespot Health	$22,127.00	0.00	$-2,021,604.10	A($0.01)	N/A
(BUX)	N/A	N/A	N/A	N/A	N/A

(BUX) has lower revenue, but higher earnings than Lifespot Health.

Profitability

This table compares Lifespot Health and (BUX)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Lifespot Health	N/A	N/A	N/A
(BUX)	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for Lifespot Health and (BUX), as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifespot Health	0	0	0	0	N/A
(BUX)	0	0	0	0	N/A

Summary

Lifespot Health beats (BUX) on 1 of the 1 factors compared between the two stocks.

Lifespot Health vs. 12144 Stock

Lifespot Health (ASX:LSH) and 12144 (CNSX:IME) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, analyst recommendations, dividends and profitability.

Earnings and Valuation

This table compares Lifespot Health and 12144's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifespot Health	$22,127.00	0.00	C$-2,021,604.10	A($0.01)	N/A
12144	N/A	N/A	N/A	N/A	N/A

12144 has lower revenue, but higher earnings than Lifespot Health.

Profitability

This table compares Lifespot Health and 12144's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Lifespot Health	N/A	N/A	N/A
12144	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for Lifespot Health and 12144, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifespot Health	0	0	0	0	N/A
12144	0	0	0	0	N/A

Summary

Lifespot Health beats 12144 on 1 of the 1 factors compared between the two stocks.

Lifespot Health vs. BARD1 Life Sciences Stock

Lifespot Health (ASX:LSH) and BARD1 Life Sciences (ASX:BD1) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, profitability, dividends and risk.

Earnings & Valuation

This table compares Lifespot Health and BARD1 Life Sciences' top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifespot Health	$22,127.00	0.00	$-2,021,604.10	A($0.01)	N/A
BARD1 Life Sciences	$612,251.00	0.00	$-6,644,706.43	A($0.08)	N/A

Lifespot Health has higher earnings, but lower revenue than BARD1 Life Sciences.

Profitability

This table compares Lifespot Health and BARD1 Life Sciences' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Lifespot Health	N/A	N/A	N/A
BARD1 Life Sciences	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings for Lifespot Health and BARD1 Life Sciences, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifespot Health	0	0	0	0	N/A
BARD1 Life Sciences	0	0	0	0	N/A

Summary

Lifespot Health beats BARD1 Life Sciences on 2 of the 3 factors compared between the two stocks.

Lifespot Health vs. Charles River Laboratories International Stock

Charles River Laboratories International (CNSX:CRL) and Lifespot Health (ASX:LSH) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Analyst Recommendations

This is a summary of current recommendations and price targets for Charles River Laboratories International and Lifespot Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Charles River Laboratories International	0	0	0	0	N/A
Lifespot Health	0	0	0	0	N/A

Valuation & Earnings

This table compares Charles River Laboratories International and Lifespot Health's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Charles River Laboratories International	N/A	N/A	N/A	N/A	N/A
Lifespot Health	$22,127.00	0.00	$-2,021,604.10	A($0.01)	N/A

Charles River Laboratories International has higher earnings, but lower revenue than Lifespot Health.

Profitability

This table compares Charles River Laboratories International and Lifespot Health's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Charles River Laboratories International	N/A	N/A	N/A
Lifespot Health	N/A	N/A	N/A

Summary

Lifespot Health beats Charles River Laboratories International on 1 of the 1 factors compared between the two stocks.

Lifespot Health vs. Cryosite Stock

Cryosite (ASX:CTE) and Lifespot Health (ASX:LSH) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, risk, earnings, valuation and institutional ownership.

Earnings & Valuation

This table compares Cryosite and Lifespot Health's gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cryosite	$9.71 million	0.00	$515,455.60	A$0.01	N/A
Lifespot Health	$22,127.00	0.00	$-2,021,604.10	A($0.01)	N/A

Cryosite has higher revenue and earnings than Lifespot Health.

Profitability

This table compares Cryosite and Lifespot Health's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cryosite	N/A	N/A	N/A
Lifespot Health	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for Cryosite and Lifespot Health, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cryosite	0	0	0	0	N/A
Lifespot Health	0	0	0	0	N/A

Summary

Cryosite beats Lifespot Health on 3 of the 3 factors compared between the two stocks.

Lifespot Health vs. dorsaVi Stock

dorsaVi (ASX:DVL) and Lifespot Health (ASX:LSH) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, risk, earnings, valuation and institutional ownership.

Analyst Ratings

This is a breakdown of recent ratings and target prices for dorsaVi and Lifespot Health, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
dorsaVi	0	0	0	0	N/A
Lifespot Health	0	0	0	0	N/A

Earnings & Valuation

This table compares dorsaVi and Lifespot Health's gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
dorsaVi	$1.65 million	0.00	$-3,158,396.93	A($0.01)	N/A
Lifespot Health	$22,127.00	0.00	$-2,021,604.10	A($0.01)	N/A

Lifespot Health has lower revenue, but higher earnings than dorsaVi.

Profitability

This table compares dorsaVi and Lifespot Health's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
dorsaVi	N/A	N/A	N/A
Lifespot Health	N/A	N/A	N/A

Summary

dorsaVi beats Lifespot Health on 2 of the 3 factors compared between the two stocks.